Track Real Time Price

According to ChemAnalyst , The Fluconazole Prices moved upward across major regions during the second quarter of 2026, as manufacturers faced higher production expenses, elevated raw material costs, and disruptions across global chemical supply chains. Fluconazole, a widely used triazole antifungal pharmaceutical, remained supported by steady healthcare consumption and persistent demand for treatments targeting fungal infections. During Q2 2026, pricing conditions differed by region. In North America , Fluconazole prices increased quarter-over-quarter amid higher producer costs and strengthening healthcare-related consumption. In APAC , particularly China, prices also moved higher as increased input costs, production restrictions, feedstock disruptions, and changes to export tax rebates affected market quotations. European prices similarly advanced, although demand conditions remained comparatively weaker because of sluggish industrial activity and subdued consumer confidence in Germa...

According to ChemAnalyst , The Fluconazole prices experienced a notable upward trend during the first quarter of 2026 (January–March 2026) across major global markets, including North America, Asia-Pacific, and Europe . Rising manufacturing expenses, increasing regulatory compliance costs, higher transportation charges, and tightening supplies of pharmaceutical intermediates contributed to the positive price movement. As one of the world's most widely used antifungal active pharmaceutical ingredients (APIs), Fluconazole remains an essential component in the treatment of fungal infections, making its pricing highly sensitive to fluctuations in pharmaceutical manufacturing, raw material availability, and healthcare demand. Throughout Q1 2026, macroeconomic indicators such as inflation, industrial production, retail sales, consumer confidence, and producer price inflation significantly influenced the Fluconazole market. In addition, regional supply chain developments and changing im...

According to ChemAnalyst , The Fluconazole prices witnessed an upward trajectory across major global markets during the first quarter of 2026 , supported by higher manufacturing expenses, persistent inflationary pressures, tightening raw material availability, and stable pharmaceutical demand. As one of the world's most widely prescribed antifungal active pharmaceutical ingredients (APIs), Fluconazole remained influenced by fluctuations in production costs, transportation expenses, feedstock availability, healthcare spending, and regional manufacturing activity. Across North America, Asia Pacific, and Europe , producers encountered varying market conditions. While production costs continued to rise due to inflation and higher utility expenses, demand from hospitals, pharmaceutical manufacturers, and healthcare institutions remained resilient. Supply chain improvements reduced some logistical bottlenecks, but regional feedstock shortages and stricter environmental regulations conti...

According to ChemAnalyst ,  The Fluconazole prices experienced a notable upward trend during the first quarter of 2026 , supported by increasing production expenses, higher logistics costs, stricter manufacturing regulations, and evolving pharmaceutical demand across major global markets. North America, Asia-Pacific, and Europe all recorded quarter-over-quarter price increases, although the underlying market drivers differed by region. Fluconazole, one of the most widely prescribed antifungal active pharmaceutical ingredients (API), continues to play a critical role in the treatment of fungal infections, creating stable demand from hospitals, pharmacies, and healthcare institutions worldwide. Rising raw material costs, compliance investments, and changes in macroeconomic indicators significantly influenced the Fluconazole Price Trend during January–March 2026. Global Fluconazole Market Overview The global Fluconazole market remained resilient throughout Q1 2026 despite persistent...